Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

NCT05170919 is registered in ClinicalTrials.gov with Englewood Hospital and Medical Center as lead sponsor.

NCT NCT05170919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05170919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
Lead sponsor
Englewood Hospital and Medical Center
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
January 20, 2022
Completion date
December 31, 2026
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa with significantly low body weight